Nutex Health jumps 21%, continuing post-earnings run
Nutex Health's stock price has risen by 21% following its earnings announcement, continuing its upward trend.
At this point, one could have concluded that the recent 7-day increase of +15.4%, the trading volume that has increased 2.52 times compared to the 20-day average, and the alignment of moving averages indicate that the upward momentum may continue.
If the upward trend continues and is supported by trading volume, I will take profits at $187.0, and I will cut losses if the stock price falls below $140.25.
RSI(14) 50.4, moving averages in a positive alignment, trading volume 2.52 times the 20-day average, recent 7-day volatility +15.4%
While there are no direct similarities, it is worth referencing the overall top performance of stocks that show sustainable momentum after a short-term surge, such as VEEE, LRCX, and AMD.
Entered based on stronger-than-expected short-term upward momentum, increased trading volume, and positive news flow; however, the actual stock price quickly retraced more than anticipated, reaching the stop-loss level — this suggests a possible overreaction to short-term news or an oversight of the potential for profit-taking.
In the future, we will delay the entry timing by considering not only short-term news and technical indicators but also the sustainability of the stock price increase rate and trading volume, as well as the potential selling pressure near key resistance levels, while managing the stop-loss range more tightly.